ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,623.29
0.61%
Dow Jones
44,771.72
0.48%
Gold vs US Dollar
2,870.97
1.02%
Brent Oil
74.565
-1.81%
Bitcoin
96,835.59
-1.05%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pyxis Oncology Inc (PYXS)

  7. Pyxis Oncology Inc (PYXS) News

Pyxis Oncology (PYXS)

Pyxis Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PYXS
DateTimeSourceHeadlineSymbolCompany
04/02/202520:45Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PYXSPyxis Oncology Inc
04/02/202512:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
04/02/202512:30GlobeNewswire Inc.Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy TrialNASDAQ:PYXSPyxis Oncology Inc
23/12/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
23/12/202421:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
19/12/202422:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
19/12/202421:08GlobeNewswire Inc.Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201NASDAQ:PYXSPyxis Oncology Inc
27/11/202422:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
20/11/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
20/11/202421:05GlobeNewswire Inc.Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 DataNASDAQ:PYXSPyxis Oncology Inc
12/11/202421:37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PYXSPyxis Oncology Inc
12/11/202412:30GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
11/11/202412:00GlobeNewswire Inc.Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201NASDAQ:PYXSPyxis Oncology Inc
06/11/202421:36Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PYXSPyxis Oncology Inc
23/10/202420:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
25/09/202420:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PYXSPyxis Oncology Inc
13/09/202420:26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PYXSPyxis Oncology Inc
29/08/202411:30GlobeNewswire Inc.Pyxis Oncology to Participate in Two Upcoming Investor ConferencesNASDAQ:PYXSPyxis Oncology Inc
14/08/202420:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
14/08/202420:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
14/08/202420:05GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
29/07/202412:00GlobeNewswire Inc.Pyxis Oncology to Participate in the BTIG Virtual Biotechnology ConferenceNASDAQ:PYXSPyxis Oncology Inc
28/06/202420:30GlobeNewswire Inc.Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PYXSPyxis Oncology Inc
12/06/202420:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
10/06/202411:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
10/06/202411:30GlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Michael A. MetzgerNASDAQ:PYXSPyxis Oncology Inc
07/06/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
30/05/202411:30GlobeNewswire Inc.Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
14/05/202412:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
14/05/202411:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:PYXS

Your Recent History

LSE
AAZ
Anglo Asian Mining
LSE
SBTX
Skinbiotherapeutics
LSE
SYME
Supply@me Capital
LSE
STX
Shield Therapeutics
LSE
SCLP
Scancell
LSE
AXL
Arrow Exploration
LSE
BIRD
Blackbird
LSE
MAC
Marechale Capital
LSE
PANR
Pantheon Resources
LSE
DGI9
Digital 9 Infrastructure
LSE
GEX
Georgina Energy
LSE
POS
Plexus
LSE
MIN
Minoan
LSE
GGP
Greatland Gold
LSE
VAST
Vast Resources
LSE
QBT
Quantum Blockchain Techn...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads